BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34746019)

  • 1. HIST1H1B Promotes Basal-Like Breast Cancer Progression by Modulating CSF2 Expression.
    Liao R; Chen X; Cao Q; Wang Y; Miao Z; Lei X; Jiang Q; Chen J; Wu X; Li X; Li J; Dong C
    Front Oncol; 2021; 11():780094. PubMed ID: 34746019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMD1 promotes breast cancer aggressiveness via a spermidine-eIF5A hypusination-TCF4 axis.
    Liao R; Chen X; Cao Q; Bai L; Ma C; Dai Z; Dong C
    Breast Cancer Res; 2024 Apr; 26(1):70. PubMed ID: 38654332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
    Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
    Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness.
    Miao Z; Cao Q; Liao R; Chen X; Li X; Bai L; Ma C; Deng X; Dai Z; Li J; Dong C
    J Exp Clin Cancer Res; 2022 May; 41(1):169. PubMed ID: 35526049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop.
    Lei X; Liao R; Chen X; Wang Z; Cao Q; Bai L; Ma C; Deng X; Ma Y; Wu X; Li J; Dai Z; Dong C
    Cancer Lett; 2024 Feb; 582():216527. PubMed ID: 38048842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca
    Chen X; Cao Q; Liao R; Wu X; Xun S; Huang J; Dong C
    Theranostics; 2019; 9(1):34-47. PubMed ID: 30662552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX10 promotes the malignant biological behavior of basal-like breast cancer cells by regulating EMT process.
    Yang K; Yun F; Shi L; Liu X; Jia YF
    Heliyon; 2023 Dec; 9(12):e23162. PubMed ID: 38144326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBX7 regulates metastasis of basal-like breast cancer through Twist1/EphA2 pathway.
    Dai T; Liu Y; Cao R; Cao J
    Transl Oncol; 2022 Oct; 24():101468. PubMed ID: 35843065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ME1 promotes basal-like breast cancer progression and associates with poor prognosis.
    Liao R; Ren G; Liu H; Chen X; Cao Q; Wu X; Li J; Dong C
    Sci Rep; 2018 Nov; 8(1):16743. PubMed ID: 30425310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-31 Receptor α Is Required for Basal-Like Breast Cancer Progression.
    He Y; Zhang X; Pan W; Tai F; Liang L; Shi J
    Front Oncol; 2020; 10():816. PubMed ID: 32528891
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigation of Transcript Variant 6 of
    Zhang X; O'Brien D; Zhang X
    Oxid Med Cell Longev; 2022; 2022():7078787. PubMed ID: 36071863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
    Shepherd JH; Uray IP; Mazumdar A; Tsimelzon A; Savage M; Hilsenbeck SG; Brown PH
    Oncotarget; 2016 Mar; 7(11):13106-21. PubMed ID: 26894864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MFAP5 promotes basal-like breast cancer progression by activating the EMT program.
    Wu Y; Wu P; Zhang Q; Chen W; Liu X; Zheng W
    Cell Biosci; 2019; 9():24. PubMed ID: 30899449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program.
    Wu X; Li X; Fu Q; Cao Q; Chen X; Wang M; Yu J; Long J; Yao J; Liu H; Wang D; Liao R; Dong C
    J Exp Med; 2017 Apr; 214(4):1065-1079. PubMed ID: 28270406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-1 downregulation promotes basal-like breast cancer cell proliferation and migration associated with DNA methylation.
    Wang C; Chen S; Zhang R; Chen M; Yang X; He Y; Shangguan Z; Mao Q; Zhang Z; Ying S
    Oncol Lett; 2024 Jul; 28(1):295. PubMed ID: 38737975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications.
    Han YJ; Boatman SM; Zhang J; Du XC; Yeh AC; Zheng Y; Mueller J; Olopade OI
    Sci Rep; 2018 Oct; 8(1):15572. PubMed ID: 30349062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
    Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
    Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
    Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT signaling pathway regulator-
    Zhou Y; Li C; Peng J; Luo P; Xie C; Liu S; Chen G; Li T
    J Thorac Dis; 2020 Jul; 12(7):3478-3487. PubMed ID: 32802426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.
    Jin Y; Han B; Chen J; Wiedemeyer R; Orsulic S; Bose S; Zhang X; Karlan BY; Giuliano AE; Cui Y; Cui X
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S758-66. PubMed ID: 25124473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.